In summary, our results showed that miR-3666 targeting EphA3 downregulated EphA3 expression and thereby suppressed the melanoma cell proliferation and migration through disruption of ERK1/2 and p38 MAPK signaling pathways. The gene discussed is MAPK3; the disease is melanoma.